• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Biogen splits R&D executive role, promoting interim head Singhal

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 05, 2023 at 04:52: PM
via After a year without a permanent head of research and development, Biogen said Thursday it is splitting the role between two executives, promoting interim R&D chief Priya Singhal to run development and undertaking a search for a new research leader.

article source
 




Top Bottom
Back
Quote